Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does pindolol improve antidepressant action?

F Artigas1, P Celada, M Laruelle

  • 1Dept of Neurochemistry, Institut d'Investigacions Biomèdiques de Barcelona (CSIC-IDIBAPS) Rosselló 161, 08036 Barcelona, Spain. fapnqi@iibb.csic.es

Trends in Pharmacological Sciences
|May 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of serum and endometrial progesterone in determining endometrial receptivity.

Human reproduction (Oxford, England)·2021
Same author

In vivo glutamate clearance defects in a mouse model of Lafora disease.

Experimental neurology·2019
Same author

Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2018
Same author

Corrigendum: Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study.

Human reproduction (Oxford, England)·2017
Same author

PET imaging of dopamine-D2 receptor internalization in schizophrenia.

Molecular psychiatry·2017
Same author

Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study.

Human reproduction (Oxford, England)·2017
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Pindolol enhances antidepressant effects by interacting with serotonin and beta-adrenoceptors. This review discusses controversial data on its mechanism of action for developing faster antidepressant therapies.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Pindolol, a beta-adrenoceptor and 5-HT(1A/1B) receptor ligand, has been used since 1994 to augment antidepressant drug efficacy.
  • Its primary use is with selective serotonin reuptake inhibitors (SSRIs) acting on 5-HT-containing neurons.

Purpose of the Study:

  • To discuss recent controversial data regarding the mechanism of action of pindolol.
  • To explore how understanding pindolol's action can lead to improved antidepressant therapies.

Main Methods:

  • Review of recent scientific literature and controversial data on pindolol's mechanism.
  • Analysis of pindolol's interaction with 5-HT(1A) autoreceptors and beta-adrenoceptors.

Main Results:

Related Experiment Videos

  • Initial hypothesis: Pindolol antagonizes 5-HT release by blocking midbrain raphe 5-HT(1A) autoreceptors.
  • Emerging data suggests pindolol's partial agonist properties at 5-HT(1A) and beta-adrenoceptors offer alternative explanations for its efficacy.

    • Conclusions:

    • The precise mechanism of pindolol's antidepressant augmentation is complex and debated.
    • Further research into pindolol's dual action is crucial for developing more rapid and effective antidepressant treatments.